Searchable abstracts of presentations at key conferences in endocrinology

ea0038p76 | Clinical practice/governance and case reports | SFEBES2015

Aromatase inhibitor: potential therapy for obesity related hypogonadotropic hypogonadism and gynaecomastia

Myint Khin Swe , Jose Neetha , Gmoez Javier , Ahluwalia Rupa , Venu Maya

Background: Hypogonadotropic hypogonadism (HH) is commonly associated with morbidly obesity. Gynaecomastia is associated feature of hypogonadism and can be deteriorated by testosterone therapy.History: A 49-year-old gentleman with a BMI of 53.2 kg/m2 was referred for management of obesity. He has two children (age 18 and 22). He had obesity associated comorbidities including obstructive sleep apnoea and impaired fasting glucose. He reported le...

ea0081ep34 | Adrenal and Cardiovascular Endocrinology | ECE2022

Single centre experience of assessment of adrenal incidentalomas – it’s time for a change

Naing Thin Kyi Phyu , Janebdar Husay , Jose Neetha , Saada Janak , Rochester Mark , Myint Khin Swe , Ahluwalia Rupa

Background: Adrenal incidentalomas (AIs) refer to adrenal masses discovered on imaging performed for conditions unrelated to suspected adrenal diseases. In an ageing population with improving radiological modalities, the detection of AIs has increased. While most are benign, non-functioning adenomas, some may represent functioning and/or malignant disease including adrenal carcinoma. Investigating AIs can be time-consuming and anxiety-inducing for patients, while under-investi...